Latest & greatest articles for depression

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on depression or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on depression and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for depression

1. Mental Health: Universal School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms

Mental Health: Universal School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Mental Health: Universal School-Based CBT | The Community Guide Welcome to The Community Guide! Let us know what you think of the website by completing this . Open Navigation or Search form Search Search The Community Guide You are here » Systematic Review Topic Recommended (strong evidence) February 2019 Audience Adolescents and Young Adults Children/Infants Setting School (...) Strategy Counseling Health Education Mental Health: Universal School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Tabs Snapshot Summary of CPSTF Finding The universal school-based cognitive behavioral therapy programs to prevent or reduce depression and anxiety symptoms among school-aged children and adolescents. The CPSTF also recommends for students who are assessed to be at increased risk for these conditions, and and CBT to reduce psychological harm from

2020 Community Preventive Services Task Force

2. Mental Health: Targeted School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms

Mental Health: Targeted School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Mental Health: Targeted School-Based CBT | The Community Guide Welcome to The Community Guide! Let us know what you think of the website by completing this . Open Navigation or Search form Search Search The Community Guide You are here » Systematic Review Topic Recommended (strong evidence) February 2019 Audience Adolescents and Young Adults Children/Infants Setting School (...) Strategy Counseling Health Education Mental Health: Targeted School-Based Cognitive Behavioral Therapy Programs to Reduce Depression and Anxiety Symptoms Tabs Snapshot Summary of CPSTF Finding The targeted school-based cognitive behavioral therapy programs to reduce depression and anxiety symptoms among school-aged children and adolescents who are assessed to be at increased risk for these conditions. The CPSTF also recommends , and and CBT to reduce psychological harm from traumatic events among

2020 Community Preventive Services Task Force

3. But I am not Depressed: Antidepressants for Irritable Bowel Syndrome

But I am not Depressed: Antidepressants for Irritable Bowel Syndrome Tools for Practice is proudly sponsored by the Alberta College of Family Physicians (ACFP). ACFP is a provincial, professional voluntary organization, representing more than 4,800 family physicians, family medicine residents, and medical students in Alberta. Established over sixty years ago, the ACFP strives for excellence in family practice through advocacy, continuing medical education and primary care research. www.acfp.ca (...) January 20, 2020 But I am not Depressed: Antidepressants for Irritable Bowel Syndrome Clinical Question: Do antidepressant medications improve irritable bowel syndrome (IBS) symptoms? Bottom Line: Both tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs) may improve overall IBS symptoms. About 55% of patients treated with TCAs or SSRIs will benefit compared to ~35% with placebo. Only TCAs improve abdominal pain for ~60% of patients compared to ~30% with placebo. TCA

2020 Tools for Practice

4. Behavioural activation treatment for depression in individuals with neurological conditions: a systematic review Full Text available with Trip Pro

Behavioural activation treatment for depression in individuals with neurological conditions: a systematic review Behavioural Activation Treatment for Depression in Individuals With Neurological Conditions: A Systematic Review - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other advanced features are temporarily unavailable (...) your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Clin Rehabil Actions , 34 (3), 310-319 Mar 2020 Behavioural Activation Treatment for Depression in Individuals With Neurological Conditions: A Systematic Review , , , Affiliations Expand Affiliations 1 University of Lincoln, Lincoln, UK. 2 Lincolnshire Partnership NHS Foundation Trust, Lincoln, UK. 3 Division

2020 EvidenceUpdates

5. Prevalence of depression in adolescents in India: a meta-analysis of the observational studies

Prevalence of depression in adolescents in India: a meta-analysis of the observational studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2020 PROSPERO

6. Prevalence of depression among patients with gastric cancer: a systematic review and meta-analysis

Prevalence of depression among patients with gastric cancer: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2020 PROSPERO

7. Quality of patient-reported measurement instruments of quality of life, health-related quality of life, anxiety and depression in testicular cancer patients: a systematic review

Quality of patient-reported measurement instruments of quality of life, health-related quality of life, anxiety and depression in testicular cancer patients: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

8. Nutraceuticals for depression: a network meta-analysis

Nutraceuticals for depression: a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2020 PROSPERO

9. Omega-3 and polyunsaturated fat for prevention of depression and anxiety symptoms: systematic review and meta-analysis of randomised trials

Omega-3 and polyunsaturated fat for prevention of depression and anxiety symptoms: systematic review and meta-analysis of randomised trials Omega-3 and Polyunsaturated Fat for Prevention of Depression and Anxiety Symptoms: Systematic Review and Meta-Analysis of Randomised Trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Welcome to the new PubMed. For legacy PubMed go to . Clipboard, Search History, and several other (...) characters Choose a collection: Unable to load your collection due to an error Add Cancel Add to My Bibliography My Bibliography Unable to load your delegates due to an error Add Cancel Actions Cite Share Permalink Copy Page navigation Br J Psychiatry Actions , 1-8 2019 Oct 24 [Online ahead of print] Omega-3 and Polyunsaturated Fat for Prevention of Depression and Anxiety Symptoms: Systematic Review and Meta-Analysis of Randomised Trials , , , , , , , Affiliations Expand Affiliations 1 Senior Lecturer

2020 EvidenceUpdates

10. Esketamine (Spravato) - major depression

Esketamine (Spravato) - major depression Official address Domenico Scarlattilaan 6 ? 1083 HS Amsterdam ? The Netherlands An agency of the European Union Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000 © European Medicines Agency, 2019. Reproduction is authorised provided the source is acknowledged. EMA/578240/2019 EMEA/H/C/004535 Spravato (esketamine) An overview of Spravato and why (...) it is authorised in the EU What is Spravato and what is it used for? Spravato is a medicine used to treat adults with major depression that is resistant to treatment. It is used in combination with an SSRI or SNRI medicine (other antidepressants) when at least two other treatments have failed. Spravato contains the active substance esketamine. How is Spravato used? Spravato is available as a nasal spray to be used by the patient in a clinic or doctor’s office, under the direct supervision of a healthcare

2020 European Medicines Agency - EPARs

11. The relationship between vegetables and fruit intake and common mental disorders (depression and anxiety) in adolescents

The relationship between vegetables and fruit intake and common mental disorders (depression and anxiety) in adolescents Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2020 PROSPERO

12. The effects of mindfulness-based interventions on symptoms of depression, anxiety, and cancer-related fatigue in oncology patients: a systematic review and meta-analysis

The effects of mindfulness-based interventions on symptoms of depression, anxiety, and cancer-related fatigue in oncology patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

13. The effectiveness of web-based acceptance and commitment therapy for depression, anxiety, quality of life, and psychological flexibility

The effectiveness of web-based acceptance and commitment therapy for depression, anxiety, quality of life, and psychological flexibility Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

14. The efficacy and safety of nonpharmacological treatments for postpartum depression: protocol for a systematic review and Bayesian network meta-analysis of randomized controlled trials

The efficacy and safety of nonpharmacological treatments for postpartum depression: protocol for a systematic review and Bayesian network meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

15. Use of currently continuous stimulation for the treatment of major depression: systematic review and meta-analysis

Use of currently continuous stimulation for the treatment of major depression: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2020 PROSPERO

16. Understanding the links between reassurance seeking and depression and anxiety: a meta analysis

Understanding the links between reassurance seeking and depression and anxiety: a meta analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2020 PROSPERO

17. Treatment of depression in adults with epilepsy

Treatment of depression in adults with epilepsy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2020 PROSPERO

18. The timing of early life adverse events and depressive disorders: a systematic review and meta-analysis

The timing of early life adverse events and depressive disorders: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2020 PROSPERO

19. Efficacy of ketamine augmented with psychotherapy in treating major depression

Efficacy of ketamine augmented with psychotherapy in treating major depression Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2020 PROSPERO

20. Comparison of the efficacies of transcranial direct current stimulation (tDCS) alone with tDCS-based combination therapies on major depression in adults: systematic review and meta-analysis

Comparison of the efficacies of transcranial direct current stimulation (tDCS) alone with tDCS-based combination therapies on major depression in adults: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO